These results, along with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 aid the notion of targeting ACKR3 as a unique strategy to modulate the opioid procedure, which could open new therapeutic avenues for opioid-related Issues. Helps to scale back chronic suffering https://thomasq468ngy3.illawiki.com/user